Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 14, 2020 - Issue
Submit an article Journal homepage
184
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Effects of Apatinib on the Pharmacokinetics of Nifedipine and Warfarin in Patients with Advanced Solid Tumors

Yun-Ting Zhu1 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China
,
Zan Teng2 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, People’s Republic of China;3 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, People’s Republic of China
,
Yi-Fan Zhang1 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-9164-8309
ORCID Icon,
Wei Li1 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China
,
Li-Xia Guo1 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China
,
Yun-Peng Liu2 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, People’s Republic of China;3 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-9645-7990
ORCID Icon,
Xiu-Juan Qu2 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, People’s Republic of China;3 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, People’s Republic of China
,
Quan-Ren Wang4 Department of Clinical Research and Development, Jiangsu Hengrui Medicine Co., Ltd., Shanghai, People’s Republic of China
,
Si-Yuan Mao4 Department of Clinical Research and Development, Jiangsu Hengrui Medicine Co., Ltd., Shanghai, People’s Republic of China
,
Xiao-Yan Chen1 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China
&
Da-Fang Zhong1 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China
 show all
Pages 1963-1970 | Published online: 20 May 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.